An experimental COVID-19 treatment pill called Molnupiravir being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc and ...
The company records direct sales and alliance revenues from its partner, BioNTech BNTX, for the COVID-19 vaccine, Comirnaty, and product revenues from its oral antiviral pill for COVID ...
For people with long Covid, finding some relief today rests ... right to make well-informed decisions about accessing promising drugs with reasonable safety profiles. Without treatment, 400 ...